TRON GROUP (TGRP) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 45 70 sessions, October 21, 2025 to October 21, 2026
- Largest daily move
- +86.5% close of May 6, 2026
- 1-year change
- -31.7% closing prices, October 21, 2025 to October 21, 2026
- 1-month change
- +10.7% closing prices, August 28, 2026 to October 21, 2026
Company Description
TRON GROUP (OTC: TGRP) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $6.1M.
TGRP has declined 31.7% over the past year. The last closing price was $0.0332.
This page collects what Stock Titan holds for TGRP, including price data, latest news, and short interest trends.
Stock Performance
TRON GROUP (TGRP) closed at $0.0332 on October 21, 2026. Over the past 12 months, the price has lost 31.7%.
TGRP Metrics & Rankings
Price returns through October 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
TRON GROUP has 6 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include clinical trial, acquisition, partnership, crypto. View all TGRP news →
SEC Filings
Short Interest History
Short interest in TRON GROUP (TGRP) currently stands at 1.6 thousand shares, representing 0.0% of the shares outstanding. Since October 2025, short interest has increased by 41.4%.
Days to Cover History
Days to cover for TRON GROUP (TGRP) currently stands at 1.0 days, down 99.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
TGRP Company Profile & Sector Positioning
TRON GROUP (TGRP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TGRP often look at related companies in the same sector, including ASEP MEDICAL HOLDINGS INC (SEPSF), NYMOX PHARM CORP (NYMXF), ORGENESIS INC (ORGS), KANE BIOTECH INC (KNBIF), and BIOPHYTIS SA (BPTSY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TGRP's relative position within its industry.